We found the serum iNOS activity in vitiligo patients' group is significantly higher than that in the normal control group (15.40±3.98 U/ml vs.13.29±2.45 U/ml; u = 6.58, P<0.01) (Figure 1A). The gene discussed is NOS2; the disease is vitiligo.